Vasomedical to Report Second Quarter 2013 Results on August 13, 2013
Management to hold investor conference call on August 14th at 11 a.m. ET
WESTBURY, N.Y., Aug. 6, 2013 /PRNewswire/ -- Vasomedical, Inc. (OTC BB: VASO), announced today that it will release its financial results for the three months ended June 30, 2013 on Tuesday, August 13, 2013.
The Company will host a conference call the following day on Wednesday, August 14th at 11:00 a.m. ET featuring remarks by Jun Ma, Ph.D., President and CEO of Vasomedical, and Michael Beecher, Chief Financial Officer of Vasomedical. To dial into the conference call, please dial 1-866-393-1344 from the U.S. or 1-631-291-4669 internationally. All dial-in participants must use the following code to access the call: 26595138. Please call at least five minutes before the scheduled start time. The conference call will also be available via webcast and can be accessed through the Investor Relations section of Vasomedical's website, www.vasomedical.com, and www.kcsa.com. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast.
A replay of the conference call will be available approximately two hours after completion of the live conference call at www.vasomedical.com or www.kcsa.com. To access the dial-in replay of the call, which will be available until September 16, 2013, please dial 1-855-859-2056 or 1-404-537-3406. All dial-in participants must use the following code to access the call: 26595138.
Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products. The Company's main proprietary products are EECP® Therapy systems, the gold standard of ECP treatment. The Company operates through three wholly owned subsidiaries: VasoSolutions, Vasomedical Global and VasoHealthcare. VasoSolutions manages and coordinates the design, manufacture and sales of EECP® Therapy systems, and other medical equipment operations; Vasomedical Global operates the Company's China-based subsidiaries; and VasoHealthcare is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments. Additional information is available on the Company's website at www.vasomedical.com.
SOURCE Vasomedical, Inc.
More by this Source
FDA Reclassifies ECP Devices for Refractory Angina as Class II
Jan 06, 2014, 16:25 ET
Vasomedical Recorded 33% Year-over-year Growth in Revenue for the Third Quarter of 2013
Nov 14, 2013, 08:00 ET
Vasomedical Again Named on Deloitte's Technology Fast 500 List
Nov 13, 2013, 08:45 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.